Improved Ejaculatory Latency, Control and Sexual Satisfaction When PSD502 is Applied Topically in Men with Premature Ejaculation: Results of a Phase III, Double-Blind, Placebo-Controlled Study

Journal of Sexual Medicine

Volumn 7, Issue 9, 2010, Pages 3179-3189

  Carson, Culley ^a   Wyllie, Michael ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Plethora Solutions Ltd   (United Kingdom)

Author keywords

Intravaginal ejaculatory latency time; Lidocaine; Premature ejaculation; Premature ejaculation Treatment; Prilocaine; PSD502

Indexed keywords

ANTIDEPRESSANT AGENT; EMLA; PLACEBO; PSD 502; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CANADA; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; EJACULATION; ELECTROCARDIOGRAPHY; EMOTIONAL STRESS; ERECTILE DYSFUNCTION; HEADACHE; HEART RATE; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERCHOLESTEROLEMIA; HYPESTHESIA; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OFF LABEL DRUG USE; PHASE 3 CLINICAL TRIAL; PHYSICAL EXAMINATION; POLAND; PREMATURE EJACULATION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; SIDE EFFECT; TREATMENT DURATION; UNITED STATES;

EID: 77956284757     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01913.x     Document Type: Article

References (26)

1. McMahon CG, Althof S, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikon PG, Becher E, Broderick GA, Buvat J, Dabeesk K, Giraldi A, Giuliano F, Hellstrom W, Incrocci L, Laan E, Meuleman E, Perelman M, Rosen R, Rowland D, Segraves R. An evidence-based definition of lifelong premature ejaculation. Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008, 5:1590-606.
2. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.
3. Dunn KM, Croft PR, Hackett GI. Sexual problems: A study of the prevalence and need for health care in the general population. Fam Pract 1998, 15:519-24.
4. Frank E, Anderson C, Rubinstein D. Frequency of sexual dysfunction in " normal" couples. N Engl J Med 1978, 299:111-5.
5. Reading AE, Wiest WM. An analysis of self-reported sexual behavior in a sample of normal males. Arch Sex Behav 1984, 13:69-83.
6. Rowland D, Perleman M, Althof S, Barada J, McCullough A, Bull S, Jamieson C, Ho KF. Self-reported premature ejaculation and aspects of sexual functioning and satisfaction. J Sex Med 2004, 1:225-32.
7. Simons JS, Carey MP. Prevalence of sexual dysfunctions: Results from a decade of research. Arch Sex Behav 2001, 30:177-219.
8. Waldinger MD, Schweitzer DH, Olivier B. On-demand SSRI treatment of premature ejaculation: Pharmacodynamic limitations for relevant ejaculation delay and consequent solutions. J Sex Med 2005, 2:121-31.
9. Powell JA, Wyllie MG. " Up and coming" treatments for premature ejaculation: Progress towards an approved therapy. Int J Impot Res 2009, 21:107-15.
10. Morales A, Barada J, Wyllie MG. A review of the current status of topical treatments for premature ejaculation. BJU Int 2007, 100:493-501.
11. Shindel A, Nelson C, Brandes S. Urologist practice patterns in the management of premature ejaculation: A nationwide survey. J Sex Med 2008, 5:199-205.
12. Henry R, Morales A, Wyllie MG. TEMPE: Topical eutectic-like mixture for premature ejaculation. Expert Opin Drug Deliv 2008, 5:251-61.
13. Dinsmore WW, Hackett G, Goldmeier D, Waldinger M, Dean J, Wright P, Calendar M, Wylie K, Novak C, Keywood C, Heath P, Wyllie M. Topical eutectic mixture for premature ejaculation (TEMPE): A novel aerosol-delivery form of lidocaine-prilocaine for treating premature ejaculation. BJU Int 2007, 99:369-75.
14. Henry R, Morales A. Topical lidocaine prilocaine spray for the treatment of premature ejaculation: A proof of concept study. Int J Impot Res 2003, 15:277-81.
15. Dinsmore W, Wyllie M. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: Results of a phase III, multicentre, double-blind, placebo-controlled study. BJU Int 2009, 103:940-9.
16. Draft guidance for industry, patient reported outcome measures: Use in medical product development to support labeling claims. http://www.fda.gov/cder/guidance/5460dft.pdf, US FDA, Available at: (accessed January 14, 2009
17. Althof S, Rosen R, Symonds T, Mundayat R, May K, Abraham L. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med 2006, 3:465-75.
18. Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The premature ejaculation profile: Validation of self-reported outcome measures for research and practice. BJU Int 2008, 103:358-64.
19. Diagnostic and statistical manual of mental disorders, DSM-IV-TR 2000, American Psychiatric Association, 4th, edition, Test revision, Washington, DC, American Psychiatric Association
20. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999, 11:319-26.
21. Wiens B. A fixed sequence bonferroni procedure for testing multiple endpoints; pharmaceut. Statistics 2003, 2:211-5.
22. Waldinger M, Zwindeerman A, Olivier B, Schweitzer D. Geometric mean IELT and premature ejaculation: Appropriate statistics to avoid overestimation of treatment efficacy. J Sex Med 2008, 5:492-9.
23. Patrick DL, Althof SE, Pryor JL. Premature ejaculation: An observational study of men and their partners. J Sex Med 2005, 2:358-67.
24. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time. J Sex Med 2005, 2:492-7.
25. Althof SE, Symonds T. Patient reported outcomes used in the assessment of premature ejaculation. Urol Clin North Am 2007, 34:581-9.
26. Waldinger M, McIntosh J, Schweitzer D. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med 2009, 6:2888-95.